These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19159827)

  • 21. Sequestering of the prehairpin intermediate of gp41 by peptide N36Mut(e,g) potentiates the human immunodeficiency virus type 1 neutralizing activity of monoclonal antibodies directed against the N-terminal helical repeat of gp41.
    Gustchina E; Bewley CA; Clore GM
    J Virol; 2008 Oct; 82(20):10032-41. PubMed ID: 18667502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ELDKWA-epitope-specific monoclonal antibodies inhibit HIV env-mediated syncytium formation.
    Zhang G; Chen YH
    Immunobiology; 2003; 207(4):259-64. PubMed ID: 12952348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Covalent fusion inhibitors targeting HIV-1 gp41 deep pocket.
    Bai Y; Xue H; Wang K; Cai L; Qiu J; Bi S; Lai L; Cheng M; Liu S; Liu K
    Amino Acids; 2013 Feb; 44(2):701-13. PubMed ID: 22961335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and evaluation of antiretroviral peptides corresponding to the C-terminal heptad repeat region (C-HR) of human immunodeficiency virus type 1 envelope glycoprotein gp41.
    Soonthornsata B; Tian YS; Utachee P; Sapsutthipas S; Isarangkura-na-Ayuthaya P; Auwanit W; Takagi T; Ikuta K; Sawanpanyalert P; Kawashita N; Kameoka M
    Virology; 2010 Sep; 405(1):157-64. PubMed ID: 20580393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fusion intermediates of HIV-1 gp41 as targets for antibody production: design, synthesis, and HR1-HR2 complex purification and characterization of generated antibodies.
    Mzoughi O; Gaston F; Granados GC; Lakhdar-Ghazal F; Giralt E; Bahraoui E
    ChemMedChem; 2010 Nov; 5(11):1907-18. PubMed ID: 20922745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A recombinant mimetics of the HIV-1 gp41 prehairpin fusion intermediate fused with human IgG Fc fragment elicits neutralizing antibody response in the vaccinated mice.
    Qi Z; Pan C; Lu H; Shui Y; Li L; Li X; Xu X; Liu S; Jiang S
    Biochem Biophys Res Commun; 2010 Jul; 398(3):506-12. PubMed ID: 20599765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The mechanism by which molecules containing the HIV gp41 core-binding motif HXXNPF inhibit HIV-1 envelope glycoprotein-mediated syncytium formation.
    Huang JH; Yang HW; Liu S; Li J; Jiang S; Chen YH
    Biochem J; 2007 May; 403(3):565-71. PubMed ID: 17223796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different from the HIV fusion inhibitor C34, the anti-HIV drug Fuzeon (T-20) inhibits HIV-1 entry by targeting multiple sites in gp41 and gp120.
    Liu S; Lu H; Niu J; Xu Y; Wu S; Jiang S
    J Biol Chem; 2005 Mar; 280(12):11259-73. PubMed ID: 15640162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of nonpolar substitutions of the conserved Phe11 in the fusion peptide of HIV-1 gp41 on its function, structure, and organization in membranes.
    Pritsker M; Rucker J; Hoffman TL; Doms RW; Shai Y
    Biochemistry; 1999 Aug; 38(35):11359-71. PubMed ID: 10471286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The C34 Peptide Fusion Inhibitor Binds to the Six-Helix Bundle Core Domain of HIV-1 gp41 by Displacement of the C-Terminal Helical Repeat Region.
    Louis JM; Baber JL; Clore GM
    Biochemistry; 2015 Nov; 54(45):6796-805. PubMed ID: 26506247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and characterization of a subpocket on the N-trimer of HIV-1 Gp41: implication for viral entry and drug target.
    Qiu Z; Chong H; Yao X; Su Y; Cui S; He Y
    AIDS; 2015 Jun; 29(9):1015-24. PubMed ID: 26125136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paramyxovirus fusion (F) protein: a conformational change on cleavage activation.
    Dutch RE; Hagglund RN; Nagel MA; Paterson RG; Lamb RA
    Virology; 2001 Mar; 281(1):138-50. PubMed ID: 11222104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conserved residue Lys574 in the cavity of HIV-1 Gp41 coiled-coil domain is critical for six-helix bundle stability and virus entry.
    He Y; Liu S; Jing W; Lu H; Cai D; Chin DJ; Debnath AK; Kirchhoff F; Jiang S
    J Biol Chem; 2007 Aug; 282(35):25631-9. PubMed ID: 17616522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel HIV-1 gp41 tripartite model for rational design of HIV-1 fusion inhibitors with improved antiviral activity.
    Su S; Wang Q; Xu W; Yu F; Hua C; Zhu Y; Jiang S; Lu L
    AIDS; 2017 Apr; 31(7):885-894. PubMed ID: 28121713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody elicited against the gp41 N-heptad repeat (NHR) coiled-coil can neutralize HIV-1 with modest potency but non-neutralizing antibodies also bind to NHR mimetics.
    Nelson JD; Kinkead H; Brunel FM; Leaman D; Jensen R; Louis JM; Maruyama T; Bewley CA; Bowdish K; Clore GM; Dawson PE; Frederickson S; Mage RG; Richman DD; Burton DR; Zwick MB
    Virology; 2008 Jul; 377(1):170-83. PubMed ID: 18499210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel bispecific peptide HIV-1 fusion inhibitor targeting the N-terminal heptad repeat and fusion peptide domains in gp41.
    Jiang X; Jia Q; Lu L; Yu F; Zheng J; Shi W; Cai L; Jiang S; Liu K
    Amino Acids; 2016 Dec; 48(12):2867-2873. PubMed ID: 27631437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization and HIV-1 fusion inhibitory properties of monoclonal Fabs obtained from a human non-immune phage library selected against diverse epitopes of the ectodomain of HIV-1 gp41.
    Louis JM; Bewley CA; Gustchina E; Aniana A; Clore GM
    J Mol Biol; 2005 Nov; 353(5):945-51. PubMed ID: 16216270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Addition of artificial salt bridge by Ile646Lys mutation in gp41 coiled-coil domain regulates 6-helical bundle formation.
    Zhao L; Hu ZW; Tong P; Chen YX; Zhao YF; Li YM
    Bioorg Med Chem Lett; 2013 May; 23(9):2727-32. PubMed ID: 23522564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and characterization of four novel monoclonal antibodies specific to N51(L6)C46 polypeptide simulating fusogenic core structure of GP41 subunit of HIV-1.
    Chen Z; Hong L; Li Z; Fan D; Huang Q; Wang H; Li Z; Xu Z
    Hybridoma (Larchmt); 2006 Oct; 25(5):278-82. PubMed ID: 17044783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The hydrophobic pocket contributes to the structural stability of the N-terminal coiled coil of HIV gp41 but is not required for six-helix bundle formation.
    Dwyer JJ; Hasan A; Wilson KL; White JM; Matthews TJ; Delmedico MK
    Biochemistry; 2003 May; 42(17):4945-53. PubMed ID: 12718536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.